Singh Arunima, Kett Warren C, Severin India C, Agyekum Isaac, Duan Jiana, Amster I Jonathan, Proudfoot Amanda E I, Coombe Deirdre R, Woods Robert J
Complex Carbohydrate Research Center and, University of Georgia, Athens, Georgia 30602.
Molecular Immunology, School of Biomedical Sciences, CHIRI Biosciences Research Precinct, Faculty of Health Sciences, Curtin University, Perth 6102, Australia.
J Biol Chem. 2015 Jun 19;290(25):15421-15436. doi: 10.1074/jbc.M115.655845. Epub 2015 Apr 23.
Interactions between chemokines such as CCL5 and glycosaminoglycans (GAGs) are essential for creating haptotactic gradients to guide the migration of leukocytes into inflammatory sites, and the GAGs that interact with CCL5 with the highest affinity are heparan sulfates/heparin. The interaction between CCL5 and its receptor on monocytes, CCR1, is mediated through residues Arg-17 and -47 in CCL5, which overlap with the GAG-binding (44)RKNR(47) "BBXB" motifs. Here we report that heparin and tetrasaccharide fragments of heparin are able to inhibit CCL5-CCR1 binding, with IC50 values showing strong dependence on the pattern and extent of sulfation. Modeling of the CCL5-tetrasaccharide complexes suggested that interactions between specific sulfate and carboxylate groups of heparin and residues Arg-17 and -47 of the protein are essential for strong inhibition; tetrasaccharides lacking the specific sulfation pattern were found to preferentially bind CCL5 in positions less favorable for inhibition of the interaction with CCR1. Simulations of a 12-mer heparin fragment bound to CCL5 indicated that the oligosaccharide preferred to interact simultaneously with both (44)RKNR(47) motifs in the CCL5 homodimer and engaged residues Arg-47 and -17 from both chains. Direct engagement of these residues by the longer heparin oligosaccharide provides a rationalization for its effectiveness as an inhibitor of CCL5-CCR1 interaction. In this mode, histidine (His-23) may contribute to CCL5-GAG interactions when the pH drops just below neutral, as occurs during inflammation. Additionally, an examination of the contribution of pH to modulating CCL5-heparin interactions suggested a need for careful interpretation of experimental results when experiments are performed under non-physiological conditions.
趋化因子如CCL5与糖胺聚糖(GAGs)之间的相互作用对于形成趋触性梯度以引导白细胞迁移至炎症部位至关重要,而与CCL5具有最高亲和力的GAGs是硫酸乙酰肝素/肝素。CCL5与其在单核细胞上的受体CCR1之间的相互作用是通过CCL5中的精氨酸残基Arg-17和-47介导的,这些残基与GAG结合(44)RKNR(47)“BBXB”基序重叠。在此,我们报告肝素和肝素的四糖片段能够抑制CCL5-CCR1结合,IC50值显示出对硫酸化模式和程度的强烈依赖性。CCL5-四糖复合物的模型表明,肝素的特定硫酸根和羧酸根基团与蛋白质的Arg-17和-47残基之间的相互作用对于强效抑制至关重要;发现缺乏特定硫酸化模式的四糖优先在不利于抑制与CCR1相互作用的位置结合CCL5。与CCL5结合的12聚体肝素片段的模拟表明,该寡糖更倾向于与CCL5同二聚体中的两个(44)RKNR(47)基序同时相互作用,并与两条链上的Arg-47和-17残基结合。较长的肝素寡糖直接与这些残基结合,为其作为CCL5-CCR1相互作用抑制剂的有效性提供了合理依据。在这种模式下,当pH值降至略低于中性时,如在炎症期间发生的情况,组氨酸(His-23)可能有助于CCL5-GAG相互作用。此外,对pH值调节CCL5-肝素相互作用的贡献的研究表明,在非生理条件下进行实验时,需要仔细解释实验结果。